Publications by authors named "Zsolt Hepp"

Claim this Profile
R
Real-World Treatment Patterns and Outcomes Among Patients with Early Non-Small Cell Lung Cancer.
Jennifer D Deem, Zsolt Hepp, Joshua J Carlson

Curr Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world survival and economic burden among patients with locally advanced or metastatic urothelial carcinoma in the United States.
Ronald C Chen, Rupali Fuldeore, Alexandra Greatsinger, Zsolt Hepp, Qing Liu

Urol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab.
Alicia K Morgans, Guru P Sonpavde, Vanessa Shih, Phoebe Wright, Zsolt Hepp

Clin Genitourin Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding.
Andrea B Apolo, Christine Michaels-Igbokwe, Nicholas I Simon, David J Benjamin, Mallory Farrar, Zsolt Hepp

Patient· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy.
Jonathan E Rosenberg, Ronac Mamtani, Guru P Sonpavde, Yohann Loriot, Ignacio Duran, Zsolt Hepp

Eur Urol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Zsolt Hepp

J Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility.
Alicia K Morgans, Matthew D Galsky, Phoebe Wright, Zsolt Hepp, Nancy Chang

Urol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy-Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling.
Matthew D Galsky, Heidi S Wirtz, Brian Bloudek, Zsolt Hepp, Mallory Farrar

Clin Epidemiol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model.
Heidi S Wirtz, Zsolt Hepp, Simrun Grewal, Phoebe Wright, Rupali Fuldeore

Am J Manag Care· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC).
Lisa Bloudek, Phoebe Wright, Caroline McKay, Christina Louise Derleth, Jennifer Susan Lill, Zsolt Hepp

Curr Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Patient-Reported Outcomes of Advanced Urothelial Carcinoma Following Discontinuation of PD-1/L1 Inhibitor Therapy.
Alicia K Morgans, Simrun Grewal, Zsolt Hepp, Rupali Fuldeore, Shardul Odak

Clin Genitourin Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology.
Brian Bloudek, Heidi S Wirtz, Zsolt Hepp, Jack Timmons, Lisa Bloudek

Clin Epidemiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Treatment Patterns and Outcomes among Patients with De Novo Unresectable Locally Advanced or Metastatic Urothelial Cancer: A Population-Level Retrospective Analysis from Alberta, Canada.
Nimira Alimohamed, Simrun Grewal, Heidi S Wirtz, Zsolt Hepp, Stephanie Sauvageau

Curr Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with opioids in patients with locally advanced or metastatic urothelial carcinoma and matched non-cancer controls.
Matthew D Galsky, Simrun Grewal, Yutong Liu, Rupali Fuldeore, Steve Sesterhenn, Zsolt Hepp

Urol Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial.
Bradley McGregor, Peter H O'Donnell, Arjun Balar, Daniel Petrylak, Jonathan Rosenberg, Zsolt Hepp

Eur Urol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma.
Susan Martin, Sonali N Shah, Zsolt Hepp, Nimanee Harris, Alicia K Morgans

Bladder Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapy.
Zsolt Hepp, Sonali N Shah, Shang-Ying Liang, Katherine Tan, Shreya Balakrishna

Future Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis.
Alicia K Morgans, Zsolt Hepp, Sonali N Shah, Anne Shah, Allison Petrilla

Urol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database study.
Zsolt Hepp, Maureen J Lage, Ramon Espaillat, Ved V Gossain

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Intestinal Complications on Health Care Costs Among Patients With Inflammatory Bowel Disease Treated With Anti-Tumor Necrosis Factor Therapies.
David T Rubin, Jenny Griffith, Qisu Zhang, Zsolt Hepp, Allison Keshishian

Inflamm Bowel Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and treatment patterns for locally advanced or metastatic urothelial carcinoma: a systematic literature review and gap analysis.
Zsolt Hepp, Sonali N Shah, Karen Smoyer, Pratyusha Vadagam

J Manag Care Spec Pharm· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypothyroidism Treatment Among Older Adults: Evidence from a Claims Database.
Maureen J Lage, Ramon Espaillat, Jamie Vora, Zsolt Hepp

Adv Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levothyroxine Treatment of Pregnant Women with Hypothyroidism: Retrospective Analysis of a US Claims Database.
Maureen J Lage, Jamie Vora, Zsolt Hepp, Ramon Espaillat

Adv Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between adherence to levothyroxine and economic and clinical outcomes in patients with hypothyroidism in the US.
Zsolt Hepp, Maureen J Lage, Ramon Espaillat, Ved V Gossain

J Med Econ· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to thyroid hormone replacement therapy: a retrospective, claims database analysis.
Zsolt Hepp, Kathleen Wyne, Shivaji R Manthena, Siting Wang, Ved Gossain

Curr Med Res Opin· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis